What We're Reading: Page 227
Industry reads hand-picked by our editors
Mar 01, 2019
-
The New York Times
Big pharma's hunt for new drugs is pushing up cost of deals
-
Axios
Pharma's research budgets are usually bigger than its profits
-
CNN
Newly discovered Alzheimer's genes further hope for future treatments
-
Endpoints
Pfizer’s blockbuster safety issue jumps the Atlantic as EMA launches its own review of Xeljanz
-
Kaiser Health News
Americans ready to crack down on drug prices that force some to skip doses
Feb 28, 2019
Feb 27, 2019
-
Evaluate
Adcom gives Karyopharm a second chance with selinexor
-
Reuters
Germany's Merck makes $5.9 billion counterbid for Versum
-
San Francisco Business Times
Big Pharma trims projects — and a potential $1 billion in payments — from collaboration with small Peninsula biotech
-
Kaiser Health News
Meow-ch! The $48,512 cat bite
Feb 26, 2019
Feb 25, 2019
-
The New York Times
It's Time for Pharmaceutical Companies to Have Their Tobacco Moment
-
The Washington Post
Her biotech firm solves medical mysteries. (And no, it’s not Theranos.)
-
Reuters
Sinovac Biotech activates 'poison pill' defense in rare move
-
Bloomberg
How Pharma Lost Its Edge in Washington
Feb 22, 2019
Feb 21, 2019
-
The Colorado Sun
A push to fix Colorado’s lowest-in-the-nation vaccine rates has an unexpected critic: Jared Polis
-
The Wall Street Journal
Johnson & Johnson Is Subpoenaed for Talc Safety Information
-
C&EN
Epitranscriptomics: The new RNA code and the race to drug it
-
Scientific American
How drug company ads downplay risks
Previous
